Barbara-Jean Bormann-Kennedy

Barbara-Jean Bormann-Kennedy

Director/Board Member chez BIOLINERX LTD.

Fortune : 127 075 $ au 31/03/2024

65 ans
Health Technology
Consumer Services
Health Services

Profil

Barbara-Jean Bormann-Kennedy is currently serving as a Director at Rincon Pharmaceuticals, Inc. and Biotechnology Innovation Organization.
She is also an Independent Director at BioLineRx Ltd., Director at Institute For Pediatric Innovation, Inc., Independent Non-Executive Director at Xeris Biopharma Holdings, Inc., Director at Nanomedical Systems, Inc., and VP-Translational Science & Network Alliances at The Jackson Laboratory.
In her former positions, Dr. Bormann-Kennedy served as President, Chief Executive Officer & Director at BetterLife Pharma, Inc., Chief Executive Officer & Director at Harbour Antibodies BV, Chief Executive Officer & Director at Supportive Therapeutics, and Independent Non-Executive Director at Xeris Pharmaceuticals, Inc. She also held the position of Head-Strategic Alliances at Pfizer Inc. and Senior VP-Business Development & Licensing at Boehringer Ingelheim Pharmaceuticals, Inc. Additionally, she worked as a Consultant at Paperboy Ventures LLC.
Dr. Bormann-Kennedy obtained her undergraduate degree from Fairfield University and her doctorate degree from the University of Connecticut Health Center.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
07/06/2023 57 500 ( 0,04% ) 127 075 $ 31/03/2024
15/03/2024 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Barbara-Jean Bormann-Kennedy

SociétésPosteDébut
BIOLINERX LTD. Director/Board Member 19/08/2013
XERIS BIOPHARMA HOLDINGS, INC. Director/Board Member 05/10/2021
Director/Board Member -
Director/Board Member -
Director/Board Member -
Corporate Officer/Principal 01/08/2017
Director/Board Member -
Tous les postes actifs de Barbara-Jean Bormann-Kennedy

Anciens postes connus de Barbara-Jean Bormann-Kennedy

SociétésPosteFin
Director/Board Member 05/10/2021
Supportive Therapeutics Chief Executive Officer 01/07/2017
░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Barbara-Jean Bormann-Kennedy

Formation de Barbara-Jean Bormann-Kennedy

Fairfield University Undergraduate Degree
University of Connecticut Health Center Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Barbara-Jean Bormann-Kennedy

Relations

100 +

Relations au 1er degré

16

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées4
PFIZER, INC.

Health Technology

BETTERLIFE PHARMA INC.

Health Technology

BIOLINERX LTD.

Health Technology

XERIS BIOPHARMA HOLDINGS, INC.

Health Technology

Entreprise privées10

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Finance

Health Services

Health Services

Supportive Therapeutics

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Barbara-Jean Bormann-Kennedy